Choi (Jaehyuk) Lab
Pioneering therapies for immune-related diseases.
The goal of the Choi Lab at UT Southwestern to develop novel therapies for immune-related diseases by engineering novel solutions. To accomplish this, we first utilize high-dimensional approaches on human disease to identify targetable disease-promoting molecular defects. Second, we utilize engineering approaches to reverse these molecular changes.
The goal is to translate these findings to first-in-human clinical trials.
Dr. Choi the inaugural Director of the new Center for Cellular Therapies and Cancer Immunology in the Harold C. Simmons Comprehensive Cancer Center. He also serves as Vice Chair for Translational Research and Innovation in the Department of Dermatology and holds the Scheryle Simmons Patigian Distinguished Chair in Cancer Immunobiology. After completing undergraduate studies in biochemistry at Harvard University, Dr. Choi earned his medical degree and Ph.D. in immunobiology from Yale University School of Medicine. He has been recognized with a number of awards, including the Damon Runyon Clinical Investigator Award (2016), the NIH Director’s New Innovator Award (2017), and the Mark Foundation Emerging Leader Award (2022).